Obtención y evaluación preliminar de un virus canarypox recombinante como candidato a vacuna antirrábica

Zanetti, Flavia; Rudak, Liliana; Micucci, Matías; Conte Grand, Daniela; Luque, Andrea; Russo, Susana; Taboga, Oscar; Pérez, Oscar; Calamante, Gabriela.
Rev. argent. microbiol ; 44(2): 75-84, jun. 2012. ilus, graf, tab
Artigo Espanhol | LILACS | ID: lil-657615

Documentos relacionados

  1. [Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate].
  2. Construction of Vero cell-adapted rabies vaccine strain by five amino acid substitutions in HEP-Flury strain.
  3. Obtención y evaluación preliminar de un virus canarypox recombinante como candidato a vacuna antirrábica
  4. Study on an attenuated rabies virus strain CTN181-3.
  5. Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells.
  6. The ATPase ATP6V1A facilitates rabies virus replication by promoting virion uncoating and interacting with the viral matrix protein.
  7. Codon optimization of G protein enhances rabies virus-induced humoral immunity.
  8. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
  9. Development of a reporter gene assay for antibody dependent cellular cytotoxicity activity determination of anti-rabies virus glycoprotein antibodies.
  10. Rabies Vaccine Characterization by Nanoparticle Tracking Analysis.